Effect of Avastin in Juxtafoveal Telangiectasias

Sponsor: Asociación para Evitar la Ceguera en México
Study ID: NCT00406380
Phase: PHASE3
Status: Withdrawn

Conditions

Telangiectasis

Eligibility Criteria

Sex: ALL
Age: 40 Years - 70 Years
Healthy Volunteers: Not accepted

Interventions

Bevacizumab — DRUG
Intravitreal injection of Bevacizumab — PROCEDURE

Study Details

Evaluation of efficacy of Intravitreal Injection of Bevacizumab in patients with Yuxtafoveal Telangiectasias

Key Dates

First listed: Dec 4, 2006
Start date: Sep 30, 2006
Status verified: May 2024
Primary completion: Sep 30, 2006
Completion: Nov 30, 2006

Study Design

Enrollment: 0 participants (actual)
Allocation: NON_RANDOMIZED
Intervention model: FACTORIAL
Primary purpose: TREATMENT

Primary Outcome Measure

Best corrected Visual Acuity